No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4720950 |
chr7:11276392-11276393 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs556095241 |
chr7:11276405-11276406 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs549216370 |
chr7:11276453-11276454 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs115792652 |
chr7:11276479-11276480 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs541865536 |
chr7:11276481-11276482 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs12055949 |
chr7:11276492-11276493 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs527816242 |
chr7:11276510-11276511 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs540399187 |
chr7:11276549-11276550 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs560110737 |
chr7:11276584-11276585 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs532413730 |
chr7:11276587-11276588 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs10233910 |
chr7:11276602-11276603 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs568823779 |
chr7:11276623-11276624 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs202192575 |
chr7:11276643-11276644 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs77765117 |
chr7:11276657-11276658 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs397941881 |
chr7:11276669-11276670 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs190515268 |
chr7:11276672-11276673 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs149955459 |
chr7:11276674-11276675 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs568134646 |
chr7:11276679-11276680 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs533679865 |
chr7:11276746-11276747 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs10263230 |
chr7:11276747-11276748 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs368916617 |
chr7:11276752-11276753 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs571872861 |
chr7:11276760-11276761 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs10263381 |
chr7:11276859-11276860 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
24 |
rs181999423 |
chr7:11276889-11276890 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs374500999 |
chr7:11276924-11276925 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs11973276 |
chr7:11276932-11276933 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs113183652 |
chr7:11276959-11276960 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs576367856 |
chr7:11276995-11276996 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs10263522 |
chr7:11277021-11277022 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs77592352 |
chr7:11277039-11277040 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs368721180 |
chr7:11277062-11277063 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs572473978 |
chr7:11277069-11277070 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs541181244 |
chr7:11277090-11277091 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs149073642 |
chr7:11277165-11277166 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs577115579 |
chr7:11277216-11277217 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs187605890 |
chr7:11277274-11277275 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs535495396 |
chr7:11277279-11277280 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs75744311 |
chr7:11277303-11277304 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs531673405 |
chr7:11277320-11277321 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs143091486 |
chr7:11277325-11277326 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs555178713 |
chr7:11277354-11277355 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs138704239 |
chr7:11277371-11277372 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs191541520 |
chr7:11277401-11277402 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs6460795 |
chr7:11277413-11277414 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
45 |
rs539635234 |
chr7:11277427-11277428 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs118153096 |
chr7:11277430-11277431 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs6460796 |
chr7:11277475-11277476 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs569992235 |
chr7:11277483-11277484 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs375997505 |
chr7:11277496-11277497 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs535766566 |
chr7:11277504-11277505 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|